Literature DB >> 7137110

Soft agar culture of human transitional cell carcinoma colonies from urine.

W J Kirkels, O E Pelgrim, F M Debruyne, G P Vooijs, C J Herman.   

Abstract

Soft-agar culture of transitional cell carcinoma colonies from urine, bladder irrigation fluid, and transurethral resection solid tumor specimens demonstrate generally better growth of tumor cell colonies from urine than from irrigation fluid. Growth of tumor colonies from urine was adequate to evaluate presence of tumor and to study growth parameters of the tumor colonies in vitro, although the number of colonies produced from urine was inadequate to evaluate sensitivity or resistance to chemotherapeutic agents. Growth in soft agar of transitional cell carcinoma colonies from urine may offer a simple, noninvasive method of evaluating the effectiveness of therapy and the prognosis for tumor progression.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137110     DOI: 10.1093/ajcp/78.5.690

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.

Authors:  Keith Syson Chan; Inigo Espinosa; Mark Chao; David Wong; Laurie Ailles; Max Diehn; Harcharan Gill; Joseph Presti; Howard Y Chang; Matt van de Rijn; Linda Shortliffe; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

2.  Dynamics of human renal tumor colony growth in vitro.

Authors:  W F Feitz; R H Verheyen; W J Kirkels; G P Vooys; F M Debruyne; C J Herman
Journal:  Urol Res       Date:  1986

3.  Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder.

Authors:  Ken-ichi Tabata; Kazumasa Matsumoto; Sho Minami; Daisuke Ishii; Morihiro Nishi; Tetsuo Fujita; Makoto Saegusa; Yuichi Sato; Masatsugu Iwamura
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.